Diabetes collaboration to identify biomarkers

Ezose Sciences and Merck have signed a collaboration to look at changes in glycans, the sugar part of the protein-sugar complexes found on the surfaces of cells, in order to find potential biomarkers for diabetes. This project is an extension of an existing agreement, and uses Ezose's proprietary GlycanMap platform. Glycans, which make up the glycome (all the sugars found in the body, either alone or as part of other molecules), have many roles in health and disease and could have potential as targets for new therapeutics, as well as markers for diagnostics. Release (.pdf)

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.